32.40
price up icon0.47%   0.15
after-market Handel nachbörslich: 32.41 0.010 +0.03%
loading
Schlusskurs vom Vortag:
$32.25
Offen:
$32.05
24-Stunden-Volumen:
1.10M
Relative Volume:
0.91
Marktkapitalisierung:
$5.98B
Einnahmen:
$797.73M
Nettoeinkommen (Verlust:
$-325.77M
KGV:
-18.28
EPS:
-1.7725
Netto-Cashflow:
$-332.79M
1W Leistung:
+1.69%
1M Leistung:
-0.64%
6M Leistung:
-7.30%
1J Leistung:
-28.03%
1-Tages-Spanne:
Value
$31.81
$33.39
1-Wochen-Bereich:
Value
$31.44
$33.39
52-Wochen-Spanne:
Value
$27.34
$47.79

Legend Biotech Corp Adr Stock (LEGN) Company Profile

Name
Firmenname
Legend Biotech Corp Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
2,800
Name
Twitter
@LegendBiotech
Name
Nächster Verdiensttermin
2025-03-11
Name
Neueste SEC-Einreichungen
Name
LEGN's Discussions on Twitter

Vergleichen Sie LEGN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
LEGN
Legend Biotech Corp Adr
32.40 5.95B 797.73M -325.77M -332.79M -1.7725
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.04 58.93B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.60 41.29B 447.02M -1.18B -868.57M -6.1812

Legend Biotech Corp Adr Stock (LEGN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-07 Eingeleitet Cantor Fitzgerald Overweight
2024-10-08 Eingeleitet Redburn Atlantic Buy
2024-06-17 Eingeleitet Truist Buy
2024-05-24 Bestätigt H.C. Wainwright Buy
2024-05-23 Eingeleitet Deutsche Bank Buy
2024-04-17 Hochstufung Scotiabank Sector Perform → Sector Outperform
2024-04-03 Eingeleitet Cantor Fitzgerald Overweight
2024-03-13 Eingeleitet Raymond James Outperform
2023-12-19 Eingeleitet Scotiabank Sector Perform
2023-11-06 Eingeleitet Goldman Buy
2023-05-25 Eingeleitet William Blair Mkt Perform
2023-05-22 Eingeleitet Daiwa Securities Buy
2023-03-29 Eingeleitet H.C. Wainwright Buy
2023-03-24 Eingeleitet RBC Capital Mkts Outperform
2022-12-06 Eingeleitet UBS Buy
2022-11-02 Eingeleitet Evercore ISI Outperform
2022-11-01 Eingeleitet Cowen Outperform
2022-10-31 Eingeleitet Guggenheim Neutral
2022-06-17 Eingeleitet BMO Capital Markets Outperform
2022-03-15 Eingeleitet Barclays Overweight
2022-01-31 Hochstufung Morgan Stanley Equal-Weight → Overweight
2022-01-06 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-12-21 Eingeleitet Piper Sandler Overweight
2021-05-18 Eingeleitet BTIG Research Buy
2020-07-01 Eingeleitet JP Morgan Overweight
2020-07-01 Eingeleitet Jefferies Buy
2020-06-30 Eingeleitet Morgan Stanley Overweight
Alle ansehen

Legend Biotech Corp Adr Aktie (LEGN) Neueste Nachrichten

pulisher
Oct 30, 2025

Sumitomo Mitsui Trust Group Inc. Sells 11,157 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - Defense World

Oct 30, 2025
pulisher
Oct 28, 2025

OVERSEA CHINESE BANKING Corp Ltd Invests $723,000 in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

Allianz Asset Management GmbH Takes $458,000 Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat

Oct 28, 2025
pulisher
Oct 23, 2025

Legend Biotech Corporation Sponsored ADR $LEGN Shares Sold by Nordea Investment Management AB - MarketBeat

Oct 23, 2025
pulisher
Oct 21, 2025

TD Asset Management Inc Has $3.67 Million Stake in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat

Oct 21, 2025
pulisher
Oct 17, 2025

H.C. Wainwright lowers Legend Biotech stock price target to $60 on muted growth By Investing.com - Investing.com South Africa

Oct 17, 2025
pulisher
Oct 17, 2025

H.C. Wainwright lowers Legend Biotech stock price target to $60 on muted growth - Investing.com India

Oct 17, 2025
pulisher
Oct 15, 2025

Ameritas Advisory Services LLC Makes New $32,000 Investment in Arbor Realty Trust $ABR - Defense World

Oct 15, 2025
pulisher
Oct 15, 2025

Free cash flow per share of Legend Biotech Corp. Sponsored ADR – MUN:9LB - TradingView

Oct 15, 2025
pulisher
Oct 15, 2025

Ameritas Advisory Services LLC Acquires Shares of 501 JPMorgan Diversified Return International Equity ETF $JPIN - Defense World

Oct 15, 2025
pulisher
Oct 15, 2025

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Receives $69.25 Average PT from Analysts - Defense World

Oct 15, 2025
pulisher
Oct 15, 2025

Vontobel Holding Ltd. Has $368,000 Holdings in Duolingo, Inc. $DUOL - Defense World

Oct 15, 2025
pulisher
Oct 15, 2025

Vontobel Holding Ltd. Sells 1,634 Shares of Wynn Resorts, Limited $WYNN - Defense World

Oct 15, 2025
pulisher
Oct 15, 2025

Avery Dennison (NYSE:AVY) Receives “Hold (C-)” Rating from Weiss Ratings - Defense World

Oct 15, 2025
pulisher
Oct 15, 2025

Pagaya Technologies (NASDAQ:PGY) Receives Sell (D-) Rating from Weiss Ratings - Defense World

Oct 15, 2025
pulisher
Oct 15, 2025

Vontobel Holding Ltd. Makes New Investment in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World

Oct 15, 2025
pulisher
Oct 15, 2025

Krystal Biotech, Inc. $KRYS Stock Holdings Boosted by Vontobel Holding Ltd. - Defense World

Oct 15, 2025
pulisher
Oct 15, 2025

Vontobel Holding Ltd. Cuts Stock Position in Waters Corporation $WAT - Defense World

Oct 15, 2025
pulisher
Oct 15, 2025

Southern Copper Corporation $SCCO Shares Sold by Vontobel Holding Ltd. - Defense World

Oct 15, 2025
pulisher
Oct 15, 2025

Vontobel Holding Ltd. Sells 10,000 Shares of Zeta Global Holdings Corp. $ZETA - Defense World

Oct 15, 2025
pulisher
Oct 15, 2025

Bennett Associates Wealth Management Has $523,000 Holdings in JPMorgan Chase & Co. $JPM - Defense World

Oct 15, 2025
pulisher
Oct 14, 2025

Analysts Set Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Price Target at $69.25 - Defense World

Oct 14, 2025
pulisher
Oct 12, 2025

US FDA adds label warning to J&J’s and Legend Biotech’s cancer therapy By Reuters - Investing.com

Oct 12, 2025
pulisher
Oct 12, 2025

JPMorgan Chase & Co. Cuts Legend Biotech (NASDAQ:LEGN) Price Target to $76.00 - Defense World

Oct 12, 2025
pulisher
Oct 12, 2025

Mirae Asset Global Investments Co. Ltd. Has $530,000 Stock Position in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World

Oct 12, 2025
pulisher
Oct 11, 2025

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Oct 11, 2025
pulisher
Oct 10, 2025

US FDA adds boxed warning to J&J, Legend Biotech’s cancer therapy By Reuters - Investing.com

Oct 10, 2025
pulisher
Oct 10, 2025

Legend Biotech (NASDAQ:LEGN) Research Coverage Started at Cantor Fitzgerald - Defense World

Oct 10, 2025
pulisher
Oct 08, 2025

Legend Biotech Corporation Sponsored ADR $LEGN Shares Sold by Public Employees Retirement System of Ohio - Defense World

Oct 08, 2025
pulisher
Oct 06, 2025

GAMMA Investing LLC Has $30,000 Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World

Oct 06, 2025
pulisher
Oct 04, 2025

Matthews International Capital Management LLC Has $45.89 Million Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat

Oct 04, 2025
pulisher
Sep 27, 2025

Voya Investment Management LLC Takes Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat

Sep 27, 2025
pulisher
Sep 23, 2025

Harbor Capital Advisors Inc. Grows Stock Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat

Sep 23, 2025
pulisher
Sep 21, 2025

Rhumbline Advisers Buys 391 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - Defense World

Sep 21, 2025
pulisher
Sep 16, 2025

Advisors Asset Management Inc. Has $673,000 Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat

Sep 16, 2025
pulisher
Sep 15, 2025

Compared to Estimates, Legend Biotech (LEGN) Q4 Earnings: A Look at Key Metrics - MSN

Sep 15, 2025
pulisher
Sep 12, 2025

Alliancebernstein L.P. Purchases 32,101 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat

Sep 12, 2025
pulisher
Sep 12, 2025

Legend Biotech stock rating reiterated at Outperform by RBC Capital - Investing.com

Sep 12, 2025
pulisher
Sep 11, 2025

Legend Biotech Corporation Sponsored ADR $LEGN Stake Decreased by Cinctive Capital Management LP - MarketBeat

Sep 11, 2025
pulisher
Sep 11, 2025

Nomura Holdings Inc. Purchases New Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat

Sep 11, 2025
pulisher
Sep 09, 2025

Legend Biotech at Morgan Stanley Conference: CARVYKTI’s Global Impact - Investing.com

Sep 09, 2025
pulisher
Sep 08, 2025

Legend Biotech (NASDAQ:LEGN) Shares Up 5.4%Here's Why - MarketBeat

Sep 08, 2025
pulisher
Sep 07, 2025

Legend Biotech Mulling 2nd Listing in HK, Singapore, or London: Wire - AASTOCKS.com

Sep 07, 2025
pulisher
Sep 06, 2025

Northern Trust Corp Has $9.73 Million Stake in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World

Sep 06, 2025
pulisher
Sep 06, 2025

Rexel (OTCMKTS:RXLSF) Stock Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World

Sep 06, 2025
pulisher
Sep 03, 2025

Cantor Fitzgerald Expects Weaker Earnings for Legend Biotech - MarketBeat

Sep 03, 2025
pulisher
Sep 02, 2025

Legend Biotech’s SWOT analysis: carvykti success drives stock potential amid challenges - Investing.com India

Sep 02, 2025

Finanzdaten der Legend Biotech Corp Adr-Aktie (LEGN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
Kapitalisierung:     |  Volumen (24h):